BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 4,835.00
-120.00 (-2.42%)
At close: Jan 19, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 22.47 billion as of January 30, 2026. Its market cap has decreased by -29.57% in one year.
Market Cap
22.47B
Enterprise Value
25.60B
Revenue
21.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,835.00
Market Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 22.47B, a decrease of -84.06%. That is a compound annual growth rate of -46.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 23.20B | 0.85% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
| Mar 2, 2023 | 141.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 150.17B |
| LabGenomics | 134.82B |
| HLB bioStep | 132.79B |
| P&K Skin Research Center | 70.90B |
| C&R Research | 51.61B |
| WOOJUNG BIO | 39.63B |
| DT&CRO CO. | 31.07B |
| SLS BIO | 26.89B |